Analysis of Gene Expression Profiles Reveals Novel Correlations With the Clinical Course of Colorectal Cancer

Authors: Cavalieri, Duccio1; Dolara, Piero1; Mini, Enrico1; Luceri, Cristina1; Castagnini, Cinzia1; Toti, Simona2; Maciag, Karolina1; De Filippo, Carlotta1; Nobili, Stefania1; Morganti, Maria1; Napoli, Cristina1; Tonini, Giulia3; Baccini, Michela3; Biggeri, Annibale3; Tonelli, Francesco4; Valanzano, Rosa4; Orlando, Claudio4; Gelmini, Stefania4; Cianchi, Fabio5; Messerini, Luca6; Luzzatto, Lucio7

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 16, Number 11, 2007 , pp. 535-548(14)

Publisher: Cognizant Communication Corporation

Buy & download fulltext article:

OR

Price: $79.00 plus tax (Refund Policy)

Abstract:

In order to discover potential markers of prognosis in colorectal cancer (CRC) we have determined gene expression profiles, using cDNA microarrays in CRC samples obtained from 19 patients in Dukes stages C and D, with favorable clinical course (Dukes C patients, survival >5 years after surgery, group A, n = 7) or unfavorable clinical course (Dukes stage C and D patients, survival <5 years after surgery, group B, n = 12). Gene expression was measured in RNA from each tumor, using a pool of equal amounts of RNA from all tumors as a reference. To identify and rank differentially expressed genes we used three different analytical methods: (i) Significance Analysis of Microarrays (SAM), (ii) Cox's Proportional Hazard Model, and (iii) Trend Filter (a mathematical method for the assessment of numerical trends). The level of expression of a gene in an individual tumor was regarded as of interest when that gene was identified as differentially expressed by at least two of these three methods. By these stringent criteria we identified eight genes (ITGB2, MRPS11, NPR1, TXNL2, PHF10, PRSS8, KCNK3, JAK3) that were correlated with prolonged survival after surgery. Pathway analysis showed that patients with favorable prognosis had several activated metabolic pathways (carbon metabolism, transcription, amino acid and nitrogen metabolism, signaling and fibroblast growth factor receptor pathways). To further validate individual gene expression findings, the RNA level of each gene identified as a marker with microarrays was measured by real-time RT-PCR in CRC samples from an independent group of 55 patients. In this set of patients the Cox Proportional Hazard Model analysis demonstrated a significant association between increased patient survival and low expression of ITGB2 (p = 0.011) and NPR1 (p = 0.023) genes.

Keywords: Colorectal cancer prognosis; Gene expression; Microarrays; Real-time RT-PCR

Document Type: Research article

DOI: http://dx.doi.org/10.3727/096504007783438376

Affiliations: 1: Department of Pharmacology, University of Florence, Florence, Italy 2: Department of Pharmacology, University of Florence, Florence, Italy, Department of Statistics, University of Florence, Florence, Italy 3: Department of Statistics, University of Florence, Florence, Italy 4: Department of Physiopathology, University of Florence, Florence, Italy 5: Dipartimento di Area Critica Medico Chirurgica, University of Florence, Florence, Italy 6: Department of Human Pathology and Oncology, University of Florence, Florence, Italy 7: Istituto Toscano Tumori, Florence, Italy

Publication date: 2007-11-01

More about this publication?
  • Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
    Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page